Bibliographic Info
GuidelineMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders, [3rd ed.].
Year of Publication2023
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Moderate
Clozapine should be considered for adults with a treatment-resistant psychotic disorder (including schizophrenia) under mental health specialist supervision, carefully balancing effectiveness, side-effects and individual preference.